Prediction of CTL epitopes using QM, SVM and ANN techniques. (Q45966702)

18 December 2017

title

Prediction of CTL epitopes using QM, SVM and ANN techniques. (English)

1 reference

18 December 2017

author name string

Manoj Bhasin

series ordinal

1

1 reference

18 December 2017

G P S Raghava

series ordinal

2

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

18 December 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

18 December 2017

volume

22

1 reference

18 December 2017

issue

23-24

1 reference

18 December 2017

page(s)

3195-3204

1 reference

18 December 2017

Immuno-informatics: Mining genomes for vaccine components

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Antigen processing and presentation--towards the millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Description and prediction of peptide-MHC binding: the 'human MHC project'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

T-cell antigenic sites tend to be amphipathic structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Hydrophobic strip-of-helix algorithm for selection of T cell-presented peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Statistical comparison of established T-cell epitope predictors against a large database of human and murine antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Two complementary methods for predicting peptides binding major histocompatibility complex molecules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

MHC ligands and peptide motifs: first listing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Prediction of binding to MHC class I molecules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

ProPred: prediction of HLA-DR binding sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

ProPred1: prediction of promiscuous MHC Class-I binding sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

SVM based method for predicting HLA-DRB1*0401 binding peptides in an antigen sequence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

MHCBN: a comprehensive database of MHC binding and non-binding peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Toward the Quantitative Prediction of T-Cell Epitopes: CoMFA and CoMSIA Studies of Peptides with Affinity for the Class I MHC Molecule HLA-A*0201

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Prediction of MHC class I binding peptides using profile motifs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

Large-scale computational identification of HIV T-cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.005

10.1016/J.VACCINE.2004.02.005

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

15297074

1 reference

18 December 2017